Price
No data yet.
Social Signal Score
Revenue
$4.02M+2337.42%Company Profile
- CEO
- David Christensen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
- Beta
- 1.17
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -24.76
Financials
Revenue
$4.02M+2337.4%Net Income
$-2.91MEBITDA
$656.8KFree Cash Flow
$288.5KEPS (diluted)
$-0.22Shares Outstanding (diluted)
13.22M+9.9%Operating Expenses
$1.87MCash & Debt
$1.32MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.10M | $-7.81M | $-0.62 |
| 2024 | $4.11M | $-5.56M | $-0.44 |
| 2023 | $2.41M | $-9.81M | $-0.79 |
| 2022 | $1.53M | $-5.49M | $-0.45 |
| 2021 | $437.9K | $-12.88M | $-1.12 |
| 2020 | $55.1K | $-5.90M | $-0.63 |
| 2019 | $30.1K | $-2.51M | $-0.47 |
| 2018 | $50.1K | $-2.06M | $-0.50 |
| 2017 | $29.2K | $-377.0K | $-0.11 |
| 2016 | $0.00 | $-4.21M | $-2.34 |
| 2015 | $5.4K | $-1.93M | $-7.82 |
| 2014 | $0.00 | $-4.55M | $-15.60 |
Valuation
RMTGhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsaccessnewswire.com·6h ago·Neutral
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions Company Announces Date, Time and Connection Details for Its Inaugural Investor Call Following a Strong First Half of 2026 MIAMI, FL / ACCESS Newswire / August 19, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the connection details for its first-ever in…
View source ↗
Earnings
Wed, Aug 19(date passed)
Estimates and results for RMTG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by RMTG officers and directors.
No open-market trades in the recent filings. All 6 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
6 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.